Month: April 2022

GLEN MILLS, Pa., April 08, 2022 (GLOBE NEWSWIRE) — Axalta (NYSE: AXTA), a leading global supplier of liquid and powder coatings, will release its first-quarter 2022 financial results after the close of trading on Monday, April 25. The release and supporting materials will be posted to the Investor Relations portion of axalta.com. In addition, the company will host a conference call at 8 a.m. ET on Tuesday, April 26, 2022. Robert W. Bryant, Chief Executive Officer, and Sean Lannon, Chief Financial Officer, will review the company’s financial performance for the period. A live webcast of the conference call will also be available online at www.axalta.com/investorcall. The dial-in phone number for the conference call is 201-689-8560. For those unable to participate, a replay of the call will be available through May 3, 2022....

ADXS-PSA in combination with KEYTRUDA® in metastatic castration-resistant prostate cancer (mCRPC) is associated with prolonged overall survival in this population, particularly in patients with visceral metastasis Median overall survival of 16.4 months for patients with visceral metastases treated with ADXS-PSA in combination with KEYTRUDA® compared to ~9 months from historical data with KEYTRUDA® alone Median overall survival of 33.7 months in all mCRPC patients treated with ADXS-PSA in combination with KEYTRUDA®, as previously reported MONMOUTH JUNCTION, N.J., April 08, 2022 (GLOBE NEWSWIRE) — Advaxis, Inc. (OTCQX: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced the publication of results of their KEYNOTE-46 Phase 1/2 open-label, double-arm...

Event will feature a presentation by David Spigel, MD, chief scientific officer of the Sarah Cannon Research Institute Wednesday, April 13th @ 8:00 am ET AUSTIN, Texas, April 08, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or “the Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), today announced that it will host a webinar on a unique approach to immuno-oncology for solid tumors on Wednesday, April 13, 2022 at 8:00 am Eastern Time. The webinar will feature a presentation from medical expert David Spigel, MD, of the Sarah Cannon Research Institute, who will discuss Molecular Templates’ program, MT-6402 (targeting PD-L1), and the implications of the Phase...

NEW YORK, April 08, 2022 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with epilepsies and seizure-related disorders, today announced that management will present at the 21st Annual Needham Virtual Healthcare Conference on Thursday, April 14, 2022, at 12:45 p.m. ET. A live webcast of the virtual presentation can be accessed through the Events & Presentations section of the Company’s website at investors.ovidrx.com. An archived replay of the webcast will be available on the Company’s website following the live presentation. Ovid management will also take part on a panel focused on trends in the epilepsy therapeutic market, which is available to Needham investors and conference attendees on Monday, April 11, 2022, at...

PHOENIX, April 08, 2022 (GLOBE NEWSWIRE) — ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced its sponsorship of the 2022 Caitlin Robb Foundation Golf Tournament being held today at the Papago Golf Course in Phoenix. “ibex is delighted to support the Caitlin Robb Foundation in the fight against pediatric cancer and to help those children who, along with their families, are battling cancer,” said Bob Dechant, CEO of ibex. “There is no more devastating news for a family than a child’s cancer diagnosis. For the past six years, ibex has been a proud sponsor of this event and is committed to the search for new treatments and a cure for cancer. We need to do everything we can to cure cancer for people of all ages, especially children.”  Founded...

BOSTON, April 08, 2022 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, today announced that on April 4, 2022, the Compensation Committee of Rhythm’s board of directors granted inducement equity grants covering an aggregate of 14,380 shares of its common stock to two new employees, consisting of inducement stock options to purchase an aggregate of 9,585 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 4,795 shares of its common stock. These inducement stock options and inducement RSUs are subject to the terms of the Rhythm Pharmaceuticals, Inc. 2022 Employment Inducement Plan (the “Inducement Plan”). The Inducement Plan is...

DALLAS, April 08, 2022 (GLOBE NEWSWIRE) — Westwood Holdings Group, Inc. (NYSE:WHG) will release its first quarter 2022 earnings after the close of the New York Stock Exchange on Wednesday, April 27, 2022. Following the release, the Company will host a live audio webcast and conference call at 4:30 pm Eastern Time (3:30 pm Central Time). To listen to the conference call, dial 877-303-6235 (U.S. and Canada) or 631-291-4837 (International). The conference call will be available for replay through May 4, 2022 by dialing 855-859-2056 (U.S. & Canada) or 404-537-3406 (international) and entering passcode 1664499. The conference call will also be available via webcast and can be accessed at Westwood’s website, westwoodgroup.com, under the Investor Relations tab. Date: April 27, 2022 Time: 4:30 PM ET Listen via Internet: westwoodgroup.com/investor-relations/events-webcasts Telephone:...

New production anticipated to bring IEC to cash flow positive operations JAKARTA, INDONESIA AND DANVILLE, CA, April 08, 2022 (GLOBE NEWSWIRE) — Indonesia Energy Corporation Limited (NYSE American: INDO) (IEC), an oil and gas exploration and production company focused on Indonesia, today announced that the company has commenced drilling operations at the first of its two back-to-back producing wells (this first well is named the K-27 well) at its 63,000-acre Kruh Block. Drilling at K-27 commenced on Thursday, April 7, 2022. K-27 has a target total depth of 3,400 feet, and it is expected to take approximately 45 days to complete all drilling operations. The commencement of drilling represents a milestone in IEC’s previously announced plan to drill two new wells at Kruh Block. As an update to the drilling plan timing for 2002, IEC...

ILT2, ILT4, ILT3 and LAIR1 are myeloid checkpoints that may play a central role in establishing an immune-suppressive state in the tumor microenvironment NGM707, NGM831 and NGM438 are all engineered to release myeloid checkpoints and reprogram myeloid cells to reverse immune suppression and enhance immune response in tumors NGM707 and NGM831 are currently in the clinic, and NGM438 is anticipated to enter the clinic this quarterSOUTH SAN FRANCISCO, Calif., April 08, 2022 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, provided additional detail today on two late-breaking poster presentations it will give on Wednesday, April 13, 2022, at the American Association for Cancer Research (AACR) Annual Meeting....

– Appoints Interim Chief Financial Officer – – First Quarter Earnings Call to be Held May 16, 2022 – PORTLAND, Tenn., April 08, 2022 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a leading provider of electrical balance of system (“EBOS”) solutions for solar, battery storage and electric vehicle charging infrastructure, today announced that it has appointed Kevin Hubbard the interim Chief Financial Officer. Mr. Hubbard has served as a partner at Ham, Langston & Brezina, LLP since 2017 and has previously worked with Shoals on financial reporting. The transition will become effective May 4, 2022, when current Chief Financial Officer Philip Garton will depart. Mr. Garton informed Shoals of his intention to resign for another opportunity at a private company. The Shoals’ board of...